Home/Filings/4/0001193125-25-297551
4//SEC Filing

MORE ROBERT J 4

Accession 0001193125-25-297551

CIK 0001863127other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 5:00 PM ET

Size

5.4 KB

Accession

0001193125-25-297551

Insider Transaction Report

Form 4
Period: 2025-11-21
Transactions
  • Sale

    Common Stock

    2025-11-21$20.25/sh246,871$5,000,0263,833,425 total(indirect: See footnote)
Footnotes (3)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Alta Partners NextGen Fund II, L.P. ("APNG II") on June 26, 2025.
  • [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.25 to $21.24. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
  • [F3]These securities are held directly by APNG II. The Reporting Person is a managing director of the general partner of APNG II and shares voting and investment control with respect to the shares held by APNG II. The Reporting Person disclaims beneficial ownership of all shares held by APNG II, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001207792

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 5:00 PM ET
Size
5.4 KB